Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSAPREPITANT Cause Maternal exposure timing unspecified? 40 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Maternal exposure timing unspecified have been filed in association with FOSAPREPITANT. This represents 8.2% of all adverse event reports for FOSAPREPITANT.

40
Reports of Maternal exposure timing unspecified with FOSAPREPITANT
8.2%
of all FOSAPREPITANT reports
40
Deaths
40
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From FOSAPREPITANT?

Of the 40 reports, 40 (100.0%) resulted in death, 40 (100.0%) required hospitalization, and 40 (100.0%) were considered life-threatening.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT. However, 40 reports have been filed with the FAERS database.

What Other Side Effects Does FOSAPREPITANT Cause?

Dyspnoea (195) Infusion related reaction (167) Hypersensitivity (157) Duodenal ulcer perforation (155) Confusional state (149) Glossodynia (149) Folliculitis (146) Arthralgia (144) Blister (144) Discomfort (144)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) INFLIXIMAB (303) LEFLUNOMIDE (302) SECUKINUMAB (301)

Which FOSAPREPITANT Alternatives Have Lower Maternal exposure timing unspecified Risk?

FOSAPREPITANT vs FOSAPREPITANT DIMEGLUMINE FOSAPREPITANT vs FOSCARBIDOPA\FOSLEVODOPA FOSAPREPITANT vs FOSCARNET FOSAPREPITANT vs FOSFOMYCIN FOSAPREPITANT vs FOSFOMYCIN TROMETHAMINE

Related Pages

FOSAPREPITANT Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified FOSAPREPITANT Demographics